Therefore specifically designed c-Kit(CD117) antibodies have been developed to be the marker of ICC and ICC can be not only identified by their ability to bind to c-Kit(CD117) antibodies but also by their clear morphological features[8]–[9]. Here, KIT is linked to intrahepatic cholangiocarcinoma.